VLP Biotech, Inc.

San Diego, CA

UEI
JPNRGENTXC35
CAGE
4AX99
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3030 Bunker Hill St #117d, San Diego, CA 92109, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

SBA capabilities narrative

VLP Biotech development of epitope-focused vaccines. Our technology enables elicitation of robust antibody and CD4 T cell responses to defined protein regions. Our technology is suited for carbohydrate or other target conjugation.

Quick answers

Is VLP Biotech, Inc. registered in SAM.gov?

Yes. VLP Biotech, Inc.'s SAM.gov registration is active through January 8, 2027.

What is VLP Biotech, Inc.'s most recent federal award?

VLP Biotech, Inc.'s most recent federal grant award is An epitope-focused nanoparticle vaccine for anthrax (R44AI142939), from National Institute of Allergy and Infectious Diseases (NIH), on May 1, 2019.

On GovTribe

See VLP Biotech, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors